[go: up one dir, main page]

CN1421219A - Chinese medicine for treating women's ovary cancer and uterine myoma - Google Patents

Chinese medicine for treating women's ovary cancer and uterine myoma Download PDF

Info

Publication number
CN1421219A
CN1421219A CN01138718A CN01138718A CN1421219A CN 1421219 A CN1421219 A CN 1421219A CN 01138718 A CN01138718 A CN 01138718A CN 01138718 A CN01138718 A CN 01138718A CN 1421219 A CN1421219 A CN 1421219A
Authority
CN
China
Prior art keywords
rhizoma
radix
chinese medicine
gram
uterine myoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN01138718A
Other languages
Chinese (zh)
Other versions
CN1219525C (en
Inventor
杨桂芬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011387181A priority Critical patent/CN1219525C/en
Publication of CN1421219A publication Critical patent/CN1421219A/en
Application granted granted Critical
Publication of CN1219525C publication Critical patent/CN1219525C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to Chinese medicine and is especially one kind of Chinese medicine for treating women's ovarial tumor and uterine myoma. The Chinese medicine is prepared with 21 kinds of Chinese medicinal materials including saffron, burreed rhizome, ground bettle, nutagrass flatsedge rhizome, bitter orange, etc. The medicine is used in treating women's uterine myoma, overal tumor, ovarial cyst and other diseases; and has high curative effect.

Description

A kind of Chinese medicine for the treatment of gynecological's oophoroma, hysteromyoma
Technical field:
The present invention relates to a kind of middle medicament, particularly a kind of Chinese medicine of specially controlling hysteromyoma of gynecology, oophoroma, ovarian cyst.
Technical background:
At present, hysteromyoma, ovarian cyst, oophoroma are current gynaecological diseases, a kind of common disease that sickness rate is higher.It directly causes symptoms such as metrorrhagia, adnexitis, pelvic inflammatory disease, menoxenia, uterine erosion, leukoplakia vulvae.This kind disease doctor trained in Western medicine is taked operative treatment, and this kind Therapeutic Method is heavy to the patient body injury, the medical expense height.
And current this kind of employing treatment by Chinese herbs disease.All be that these therapies can only be kept symptom, and can not make its recovery from illness with antiinflammatory, blood stasis dispelling, therapy such as invigorate blood circulation mostly.
Suffer from this patient and come from gas more, blood circulation depending on qi flow, stagnation of QI blood ends.So blood stasis deposits in utero, uterine cavity logical, the of a specified duration inflammation of must not relaxing, inflammation is suppurated for a long time, is the disease of cyst.
Summary of the invention:
The objective of the invention is to overcome the Chinese medicinal formulae the deficiencies in the prior art, provide a kind of and can effectively cure various oophoromaes, the Chinese medicine of ovarian cyst and hysteromyoma, cervical erosion.
Technical scheme of the present invention be in prescription, added make the blood stasis dispelling of this kind gynaecopathia disappear heavily fortified point, heat-clearing and toxic substances removing, remove the rotten and let fresh grow, its concrete group part of the Chinese medicine of removing obstruction for relieving pain. and proportioning are as follows: by weight percentage: the west is spent 2-3% mountain first 4-5% turtle shell 8-10% triangular 4-5% literary composition art 4-5% leech 4-5% soil worm 4-5% Da Bei 4-5% root of Dahurain angelica 3-4% rhizoma cyperi 3-4% soap to sting the 3-4% rheum officinale 3-4% Fructus Aurantii 3-4% pseudo-ginseng 3-4% smilax 8-10% Radix Angelicae Sinensis 3-4% Hu 3-4% of unit Radix Glycyrrhizae 2-3% a thousand pieces of gold and is dialled 4-5% radix ampelopsis 4-5% oyster 8-10%
Carapax Trionycis in the side, Squama Manis, Concha Ostreae, Spina Gleditsiae, Radix Notoginseng, has the effect of hard masses softening and resolving, blood stasis dispelling evacuation of pus.Rhizoma sparganic, Rhizoma Curcumae, Stigma Croci, Hirudo have the function of blood circulation promoting and blood stasis dispelling.Bulbus Fritillariae Thunbergii, Radix Flemingiae Philippinensis have the function of detumescence and drawing out poison; The Radix Angelicae Dahuricae has the function of anti-inflammation detumescence.Fructus Aurantii, Rhizoma Cyperi, Rhizoma Corydalis, Radix Et Rhizoma Rhei have the function of dissipating depression of QI circulation of qi promoting.Radix Angelicae Sinensis, Radix Ampelopsis, Rhizoma Smilacis Glabrae have the function of the nourishing kidney of nourishing blood.Radix Glycyrrhizae is concocted all medicines.The present invention supports kidney, active blood stasis dispelling for curing mainly with regulating menstruation and activating blood, eliminating stagnation softening the hard mass, dissipating depression of QI circulation of qi promoting, YIN nourishing.By motherland's theory of Chinese medical science theory: the judgement of " healthy energy internal memory, heresy can not be done, the institute of heresy gathers, its gas must void ".The intrinsic factor that cause this kind gynaecopathia mainly are because seven emotions are disgruntled, injure liver and gall, insufficiency of the spleenly do not take the photograph, and blood-stasis internal-depression, palace gas freely do not wait category.The traditional Chinese medical science thinks that treating this disease answers " hard masses should be treated by softening, stasis of blood person disappears it, disease caused by accumulations of pathogen should be treated with therapy of dispersion, gas person row ".
The present invention compared with prior art has following advantage and good effect:
1, unique curative effect is arranged in clinical practice, suffer from this sick patient and obtained radical cure thereby make, cure rate is more than 90%.
2, the characteristics that have short treating period, instant effect simultaneously, do not recur after more.
The specific embodiment: the west spends the civilian art 25 gram leech of 15 Keshan first, 25 gram turtle shells, 50 gram triangulars, the 25 grams 25 gram eupolyphage sece steleophagas 25 gram Da Bei 25 gram roots of Dahurain angelica 15 gram rhizoma cyperis 15 gram spina gleditsiaes 15 gram rheum officinales 15 gram Fructus Aurantiis 15 gram pseudo-ginseng 20 gram smilaxs 50 gram Radix Angelicae Sinensis 15 gram corydalis tubers 15 gram Radix Glycyrrhizaes 10 gram a thousand pieces of golds to dial 25 gram radix ampelopsis, 25 gram oysters, 50 grams
Above prescription medical material is ground into fine flour, is divided into 1000 parts, is one of finished medicines in the every part of capsule of packing into.Adult's morning and evening every day twice, each 10.Warm water is taken.Avoid Herba Alii fistulosi, Bulbus Allii, raw meat, peppery.

Claims (1)

1, treatment gynecological oophoroma, the Chinese medicine of hysteromyoma, it is characterized in that its component is: by weight percentage: Stigma Croci 2-3%, Squama Manis 4-5%, Carapax Trionycis 8-10%, rhizoma sparganic 4-5%, Rhizoma Curcumae 4-5%, Hirudo 4-5%, eupolyphage sece steleophaga 4-5%, Bulbus Fritillariae Thunbergii 4-5%, Radix Angelicae Dahuricae 3-4%, Rhizoma Cyperi 3-4%, Spina Gleditsiae 3-4%, Radix Et Rhizoma Rhei 3-4%, Fructus Aurantii 3-4%, Radix Notoginseng 3-4%, Rhizoma Smilacis Glabrae 8-10%, Radix Angelicae Sinensis 3-4%, Rhizoma Corydalis 3-4%, Radix Glycyrrhizae 2-3%, a thousand pieces of gold is dialled 4-5%, Radix Ampelopsis 4-5%, Concha Ostreae 8-10%.
CNB011387181A 2001-11-27 2001-11-27 Chinese medicine for treating women's ovary cancer and uterine myoma Expired - Fee Related CN1219525C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011387181A CN1219525C (en) 2001-11-27 2001-11-27 Chinese medicine for treating women's ovary cancer and uterine myoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011387181A CN1219525C (en) 2001-11-27 2001-11-27 Chinese medicine for treating women's ovary cancer and uterine myoma

Publications (2)

Publication Number Publication Date
CN1421219A true CN1421219A (en) 2003-06-04
CN1219525C CN1219525C (en) 2005-09-21

Family

ID=4674688

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011387181A Expired - Fee Related CN1219525C (en) 2001-11-27 2001-11-27 Chinese medicine for treating women's ovary cancer and uterine myoma

Country Status (1)

Country Link
CN (1) CN1219525C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100350956C (en) * 2005-12-22 2007-11-28 陈宝贵 Medicine for treating hysteromyoma
CN101332276B (en) * 2008-07-03 2010-09-22 沈信堂 Traditional Chinese medicine for treating uterus tumour
CN102423369A (en) * 2011-12-29 2012-04-25 许从玉 Traditional Chinese medicine composition for preventing or treating ovarian cancer
CN102600406A (en) * 2012-03-29 2012-07-25 常熟市常福有机复合肥有限公司 Chinese traditional medicine treating chronic pelvic inflammatory mass and preparation method for Chinese traditional medicine

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023177835A1 (en) * 2022-03-18 2023-09-21 Smith Nichole Treatment of uterine fibroids

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100350956C (en) * 2005-12-22 2007-11-28 陈宝贵 Medicine for treating hysteromyoma
CN101332276B (en) * 2008-07-03 2010-09-22 沈信堂 Traditional Chinese medicine for treating uterus tumour
CN102423369A (en) * 2011-12-29 2012-04-25 许从玉 Traditional Chinese medicine composition for preventing or treating ovarian cancer
CN102423369B (en) * 2011-12-29 2012-09-05 许从玉 Chinese medicinal composition for preventing or treating ovarian cancer
CN102600406A (en) * 2012-03-29 2012-07-25 常熟市常福有机复合肥有限公司 Chinese traditional medicine treating chronic pelvic inflammatory mass and preparation method for Chinese traditional medicine
CN102600406B (en) * 2012-03-29 2014-02-12 常熟市常福有机复合肥有限公司 Traditional Chinese medicine treating chronic pelvic inflammatory mass and preparation method therefor

Also Published As

Publication number Publication date
CN1219525C (en) 2005-09-21

Similar Documents

Publication Publication Date Title
CN103349753B (en) Traditional Chinese medicine composition for treating kidney deficiency
CN102068661A (en) Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea
CN101337045A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN102038911A (en) Traditional Chinese medicine preparation for treating acute mastitis
CN103536748A (en) Traditional Chinese medicament for treating goiter with depression of liver to generate pathogenic fire
CN104306540B (en) A kind of treat Chinese medicine preparation of numb limbs and tense tendons and preparation method thereof after brain tumor surgery
CN102872301B (en) Anti-rheumatism medicinal liquor and using method thereof
CN101632745B (en) Chinese medicinal compound preparation for treating rheumatic and rheumatoid arthritis
CN1421219A (en) Chinese medicine for treating women's ovary cancer and uterine myoma
CN102416146B (en) Chinese medicinal composition for treating amenorrhea
CN102406765B (en) Traditional Chinese medicine composition for treating acne
CN1181842C (en) A Chinese medicinal honeyed pill for treating aseptic necrosis of femoral head
CN103251889A (en) Traditional Chinese medicine composition for treating agalactia
CN101961451A (en) Kidney-tonifying and body-strengthening oral liquid
CN1215875C (en) Peroral Chinese medicine powder for treating bone fracture and its preparing process
CN102552461B (en) Medicinal moxa roll for treating knee osteoarthritis
CN101829249A (en) Traditional Chinese medicine powder for treating rheumatoid diseases
CN101085303A (en) Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN102284035A (en) Chinese composition for treating rhinitis
CN1241587C (en) Chinese medicinal preparation for treating gynopathy
CN1382486A (en) Fengshitongluo wan for treating rheumatism
CN1189364A (en) Pregnancy promoting pill
CN105920292A (en) Chinese medicinal composition for treating acute mastitis
CN104758539A (en) Traditional Chinese medicine composition for treating debilitation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee